Indication
Pancreatic Carcinoma Non-resectable
1 clinical trial
1 product
Clinical trial
A Randomized Double Blind Study of Pancreatic Enzyme Replacement Therapy for Patients With Metastatic Pancreatic Ductal AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-11-30
Product
Pertzye